𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Salvage chemotherapy for non Hodgkin's lymphoma of unfavourable histology with a combination of ccnu and vinblastine

✍ Scribed by Dr. G. Palmieri; R. Lauria; F. Caponigro; C. Pagliarulo; V. Montesarchio; F. Nuzzo; C. Gridelli; A. R. Bianco

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
309 KB
Volume
8
Category
Article
ISSN
0278-0232

No coin nor oath required. For personal study only.

✦ Synopsis

Twenty patients with relapsed or refractory, intermediate or high grade non Hodgkin's lymphoma were treated with a combination of CCNU and vinblastine. Complete responses occurred in four patients (20 per cent), partial responses in eight (40 per cent), for an overall response rate of 60 per cent. The regimen was more effective in patients with high grade lymphoma, absence of constitutional symptoms, better response to prior treatment. Duration of response was 4,8, 16,30 months for complete responders; 2,2,6,6,6,8,9,14months for partial responders. This combination regimen seems at least as effective as most of other regimens utilized in salvage treatment of non Hodgkin's lymphomas, with a very acceptable toxicity.

πŸ“œ SIMILAR VOLUMES

Excessive chemotherapy-related granulocy
Excessive chemotherapy-related granulocytopenia in a child with non-Hodgkin's lymphoma and a congenital abnormality of purine salvage
✍ Blatt, Julie πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 356 KB

## Abstract A girl with non‐Hodgkin's lymphoma and immunodeficiency based on absence of the purine salvage pathway enzyme purine nucleoside phosphorylase experienced profound neutropenia while receiving combination chemotherapy with cyclophosphamide, vincristine, methotrexate, and prednisone (COMP)

Long-term follow-up of patients receivin
Long-term follow-up of patients receiving salvage chemotherapy for intermediate and high grade non-Hodgkin's lymphomas
✍ Dr. Raymond H. S. Liang; Edmond K. W. Chiu; T. K. Chan; David Todd; Ronald P. Ng πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 423 KB πŸ‘ 1 views

This is an analysis of the long-term follow-up data of 99 patients receiving HOAP-Bleo, IMVP-16 and PAC as salvage chemotherapy for refractory or relapsed intermediate or high grade non-Hodgkin's lymphomas. Most of the patients received HOAP-Bleo or PAC following failure of initial chemotherapy and